CRISTOFERI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.258
EU - Europa 2.789
AS - Asia 1.091
SA - Sud America 115
AF - Africa 15
OC - Oceania 1
Totale 7.269
Nazione #
US - Stati Uniti d'America 3.231
IT - Italia 862
SG - Singapore 508
RU - Federazione Russa 456
DE - Germania 413
SE - Svezia 391
IE - Irlanda 262
HK - Hong Kong 203
CN - Cina 173
GB - Regno Unito 149
BR - Brasile 101
NL - Olanda 44
ID - Indonesia 40
IN - India 40
FR - Francia 36
VN - Vietnam 34
FI - Finlandia 33
AT - Austria 23
UA - Ucraina 22
DK - Danimarca 21
CA - Canada 19
MY - Malesia 19
BE - Belgio 16
TR - Turchia 15
PT - Portogallo 9
IL - Israele 8
TW - Taiwan 8
ES - Italia 7
GR - Grecia 7
IQ - Iraq 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
PK - Pakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
CH - Svizzera 5
LT - Lituania 5
ZA - Sudafrica 5
AR - Argentina 4
EC - Ecuador 4
MM - Myanmar 4
BD - Bangladesh 3
JP - Giappone 3
KR - Corea 3
MX - Messico 3
RO - Romania 3
AZ - Azerbaigian 2
CO - Colombia 2
EG - Egitto 2
GH - Ghana 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
OM - Oman 2
PA - Panama 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.269
Città #
Ann Arbor 862
Singapore 349
Frankfurt am Main 339
Milan 309
Dublin 248
Fairfield 231
Chandler 220
Hong Kong 196
Wilmington 178
Ashburn 137
New York 124
Chicago 105
Woodbridge 104
Santa Clara 102
London 91
Seattle 89
Houston 84
Cambridge 81
Princeton 72
Shanghai 64
Rome 51
Dearborn 44
Jakarta 39
Lawrence 35
Altamura 28
Helsinki 26
Florence 25
Beijing 24
Los Angeles 23
Moscow 22
Boardman 21
San Diego 21
Monza 19
Pune 17
Nuremberg 16
Penang 16
Brussels 15
Nanjing 15
Turin 14
Jacksonville 13
Andover 12
Vienna 12
Bologna 11
Council Bluffs 11
São Paulo 10
Modena 9
Padova 9
Paris 9
Seregno 9
Toronto 9
Bari 8
Lisbon 8
Mumbai 8
Fremont 7
Guangzhou 7
Naples 7
Treviglio 7
Bratislava 6
Brno 6
Central 6
Desio 6
Detroit 6
Genoa 6
Kocaeli 6
Lappeenranta 6
Lauterbourg 6
Lissone 6
Munich 6
Rovereto 6
Athens 5
Bergamo 5
Cagliari 5
Delmar 5
Hangzhou 5
Istanbul 5
Rio de Janeiro 5
Amsterdam 4
Appiano Gentile 4
Castiglione del Lago 4
Changsha 4
Dong Ket 4
Düsseldorf 4
Jiaxing 4
Jinan 4
Kilburn 4
Meda 4
Norwalk 4
Shenyang 4
São José do Rio Preto 4
Udine 4
Bovisio-Masciago 3
Carate Brianza 3
Cesano Boscone 3
Chioggia 3
Comazzo 3
Cossato 3
Dongguan 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Totale 4.815
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 439
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 265
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 260
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 206
Precision medicine in primary biliary cholangitis 199
Risk stratification in primary sclerosing cholangitis 198
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 196
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 189
Endocrinology and Metabolic Diseases (Including Diabetes) 186
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 184
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 184
New Therapeutic Targets in Autoimmune Cholangiopathies 177
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 176
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 174
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 174
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 161
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 159
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 148
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 146
Prognostic models in primary biliary cholangitis 144
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 142
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 141
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 141
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 134
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 132
The immunobiology of female predominance in primary biliary cholangitis 131
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 124
Fibrocystic liver disease 120
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 106
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 102
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 98
A Smooth Esophageal Stricture Causing Dysphagia 92
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 91
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 91
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 90
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 89
Individualizing Care: Management Beyond Medical Therapy 89
Artificial intelligence for precision medicine in autoimmune liver disease 86
Antioxidant treatment for acute pancreatitis 84
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 84
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 81
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 79
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 76
An update on novel pharmacological agents for primary sclerosing cholangitis 75
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 69
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 68
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 66
Transient elastography in chronic liver disease: beware to the cut-offs! 65
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 61
X marks the spot in autoimmunity 60
The Role of Epigenetics in Primary Biliary Cholangitis 58
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 57
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 52
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 48
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 47
Systematic review-Pancreatic involvement in inflammatory bowel disease 43
Primary Sclerosing Cholangitis 39
Elastography in Autoimmune Liver Diseases 37
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 34
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 32
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 32
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 30
Individualizing Care: Management Beyond Medical Therapy 28
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 26
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 24
Non-invasive imaging biomarkers in chronic liver disease 19
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 17
Totale 7.628
Categoria #
all - tutte 34.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020127 0 0 0 0 0 0 0 0 0 69 42 16
2020/20211.133 29 25 184 66 88 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.166 195 303 153 143 233 130 191 111 302 405 0 0
Totale 7.628